# Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

> **NCT04855513** · NA · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 414 (estimated)

## Conditions studied

- Preeclampsia
- Preeclampsia Severe
- High Risk Pregnancy
- Eclampsia

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04855513
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-24
- **Primary completion:** 2023-04-24
- **Final completion:** 2023-12-30
- **Target enrollment:** 414 (ESTIMATED)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855513, "Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04855513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*